BrightSpring Health Q3 revenue beats; raises 2026 revenue forecast

By Reuters News


Overview

  • US home health provider's Q3 revenue rose 26% yr/yr, beating analyst expectations

  • Adjusted EBITDA for Q3 rose 42% yr/yr

  • Company raised full-year 2026 revenue and adjusted EBITDA guidance


Outlook

  • BrightSpring raises 2026 revenue forecast to $15.9 bln-$16.13 bln

  • Company expects 2026 adjusted EBITDA of $850 mln-$860 mln

  • Amedisys and LHC branches seen adding about $35 mln to 2026 adjusted EBITDA


Result Drivers

  • SEGMENT GROWTH - Co attributed Q3 revenue increase to growth in both Pharmacy Solutions and Provider Services segments

  • HIGHER REVENUE PER SCRIPT - Co said revenue and gross profit per script in Pharmacy Solutions segment increased significantly yr/yr

  • INCREASED HOME HEALTH CENSUS - Co reported higher average daily census in Home Health Care, contributing to Provider Services revenue growth


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$4.21 bln

$3.88 bln (17 Analysts)

Q3 Adjusted EBITDA

$228 mln

Q3 Gross Profit

$519 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 19 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy"

  • Wall Street's median 12-month price target for Brightspring Health Services Inc is $80.00, about 32.8% above its October 29 closing price of $60.22

  • The stock recently traded at 27 times the next 12-month earnings vs. a P/E of 36 three months ago


Reuters Recommended Reads

  • Oct 27 - Ensign Group Q3 adjusted EPS beats estimates, revenue up on higher occupancy rates

  • Oct 29 - DaVita Q3 revenue beat analyst estimates on increased average reimbursement rates

  • Oct 28 - Community Health Systems Q3 revenue misses estimates


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk